Total raised
$50K
Stage
Pre-Funding
Founded
2014
Headcount
6
HQ
Ness Ziona
Sector
Health Tech & Life Sciences
About
Novitero is a computational drug design and development company working to enable precise and effective cancer treatments. The companys technology is designed to proactively combat cancer by previewing its mutational activities and overcoming its resistance to therapies. Noviteros goal is to predict and bypass the potential mutations that cancer may adopt to resist therapies. The company uses its computational technologies to predict the mutational fingerprints implicated in drug resistance to various therapeutic targets. It then designs, validates, and out-licenses new drugs that bypass these mutations.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsBiotechnology
Business model
B2B
Highlights
1 PatentsVerified
Tags
drug-designdrug-discoverytargeted-cancer-therapycancer-therapypersonalizationpharma-companiesbioinformatics